Psychoneuroimmunology Finds Acceptance As Science Adds Evidence

Despite some scientists' skepticism and funding shortages, the nascent field of psychoneuroimmunology (PNI) is gaining greater acceptance in the mainstream medical world. PNI seeks to understand the complex communications among the brain and the immune system, and their implications for health. Only within the past two decades have researchers begun to muster experimental evidence to figure it all out. Today, powerful new molecular techniques allow scientists to detail links between stress and

Written bySteven Benowitz
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Despite some scientists' skepticism and funding shortages, the nascent field of psychoneuroimmunology (PNI) is gaining greater acceptance in the mainstream medical world. PNI seeks to understand the complex communications among the brain and the immune system, and their implications for health.

Only within the past two decades have researchers begun to muster experimental evidence to figure it all out. Today, powerful new molecular techniques allow scientists to detail links between stress and disease immunity, pinpointing changes in hormone flow and immune system cells.

According to Margaret Kemeny, an associate professor of psychiatry and biobehavioral science at the University of California, Los Angeles, PNI research has exploded in the last decade. Recent work has demonstrated that hormones and neurotransmitters released under stress can change immune cell behavior. These various cells actually have receptors to "hear" the signals, allowing the nervous, endocrine, and immune systems to "talk."

At Ohio State University in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies